HIGHLIGHTS
- who: Ken Miyaguchi from the Departmentthe University have published the research: Activated T cell therapy targeting glioblastoma cancer stem cells, in the Journal: Scientific Reports Scientific Reports
- what: The authors demonstrated the development of autologous activated T_cell therapy using three different types of antigen stimulation to pulse DCs ex vivo to identify the optimal activation conditions to generate ATCs, which can improve the efficacy of cancer immunotherapy against GSCs.
- how: The search results showed that all epitopes were highly specific to each target protein except A u00ad IM2Intron and gu00ad p100209-217-2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.